Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (PACTR202607874630774) titled 'A master protocol to investigate efficacy and safety of elecoglipron in participants with obesity or overweight with or without type 2 diabetes mellitus' on July 31.
Study Type: Interventional
Study Design:
Parallel: different groups receive different interventions at same time during study,Randomised,Simple randomization using a randomization table created by a computer software program,Central randomisation by phone/fax
Primary Sponsor: AstraZeneca AB
Condition:
Nutritional, Metabolic, Endocrine
Nutritional, Metabolic, Endocrine
Intervention:
Elecoglipron
Elecoglipron
Recruitment Status: Not Recruiti...